Trevena Announces NIH Has Resumed Recruiting Patients in Proof-of-Concept Study for TRV734 in Opioid Use Disorder
16 juin 2021 07h00 HE
|
Trevena Inc.
-- TRV734 reduced drug-seeking behavior in a preclinical model of relapse, suggesting its utility as a novel oral maintenance treatment for opioid use disorder The study is being conducted and...
Addiction: Science Drives New & Novel Treatments - A Free Webinar from the Brain & Behavior Research Foundation
30 mars 2021 09h00 HE
|
Brain & Behavior Research Foundation
New York, March 30, 2021 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Addiction: Science Drives New & Novel Treatments” on Tuesday, April...
Trevena Announces Initiation of Proof-of-Concept Study for TRV734 for Potential Treatment of Opioid Use Disorder
23 déc. 2019 07h00 HE
|
Trevena Inc.
CHESTERBROOK, Pa., Dec. 23, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
Canbiola Appoints David Woycik, Jr. to its Corporate Advisory Board and Completes a 300% Increased Investment in its Duramed Division to Combat the Opioid Crisis
06 mai 2019 11h12 HE
|
Canbiola, Inc.
Adds Pharmaceutical and Business Operations Expertise with Key Relationships to Provide Growth Opportunities for Canbiola HICKSVILLE, NY, May 06, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE...
MediXall.com Enters Partnership to Provide the First "Behavioral Health and Opioid and Substance Use Disorders" Network
09 avr. 2019 11h17 HE
|
MediXall Group, Inc.
This total network solution will position MediXall in front of many commercial group health plans & self-insured employers, creating a new high-margin revenue stream for the Company FORT...
BioCorRx Announces Formation of Scientific Advisory Board
19 févr. 2019 10h26 HE
|
BioCorRx Inc
ANAHEIM, CA, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (the “Company”), a developer and provider of advanced solutions in the treatment of substance use...
Mobile App Data Collection Shows Promise for Critical Population Health Surveys
20 déc. 2018 09h55 HE
|
Medable
PALO ALTO, Calif., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Mobile app data collection can bring access to more potential clinical study participants, reduce clinical study timeframes, and create more...
Medifirst Solutions Applauds the Passage of the Farm Bill at the American Pain Association Symposium in Philadelphia
17 déc. 2018 12h43 HE
|
Medifirst Solutions
Freehold, NJ, Dec. 17, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”): Speaking at the American Pain Association (APA) symposium...
UPDATE - New Study: Employer Reduced Opioid Use 23% with Hinge Health’s Evidence-Based Digital Back and Knee Care Programs
30 oct. 2018 11h23 HE
|
Hinge Health
New Study Demonstrates Hinge Health Reduced Employer Surgery and Opioid Claims Related to Chronic Musculoskeletal Pain SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Hinge Health, a pioneering...
New Study: Employer Reduced Opioid Use 23% with Hinge Health’s Evidence-Based Digital Back and Knee Care Programs
30 oct. 2018 08h00 HE
|
Hinge Health
SAN FRANCISCO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Hinge Health, a pioneering provider of digital care programs for people with musculoskeletal (MSK) conditions such as back or joint pain, today...